Dec. 12, 2019—A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.
Nov. 6, 2019—Gary Nabel, MD, PhD, Chief Scientific Officer and Senior Vice President of Sanofi, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 14.
Jul. 24, 2019—VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.
Sep. 20, 2018—With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.
Feb. 8, 2018—When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs.
Mar. 3, 2016—Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.
Oct. 8, 2015—Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states.
Jun. 25, 2015—Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health.